Notice: Applications, Hearings, Determinations, Etc.: Lin Zhi International Inc.

70986 Federal Register / Vol. 71, No.
235 / Thursday, December 7, 2006 / Notices
DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Schedule
Drug Enforcement Administration Drug Enforcement Administration Ethylmorphine (9190) ................... II

Hydrocodone (9193) ..................... II
Manufacturer of Controlled Importer of Controlled Substances; Levorphanol (9220) ...................... II
Substances; Notice of Registration Notice of Registration Meperidine (9230) ........................ II
Methadone (9250) ........................ II
By Notice dated July 10, 2006 and Dextropropoxyphene, bulk (non- II
By Notice dated July 19, 2006, and published in the Federal Register on dosage forms) (9273).
published in the Federal Register on July 24, 2006, (71 FR 41837–41838), Morphine (9300) ........................... II
July 26, 2006, (71 FR 42417), Lin Zhi Lipomed Inc., One Broadway, Thebaine (9333) ........................... II
International, Inc., 687 North Pastoria Cambridge, Massachusetts 02142, made Oxymorphone (9652) ................... II
Avenue, Sunnyvale, California 94085, application by renewal to the Drug Alfentanil (9737) ........................... II
made application by renewal to the Enforcement Administration (DEA) to Fentanyl (9801) ............................ II
Drug Enforcement Administration Sufentanil (9740) .......................... II
be registered as an importer of the basic
(DEA) to be registered as a bulk classes of controlled substances listed in
manufacturer of the basic classes of schedule I and II: The company plans to import
controlled substances listed in schedule analytical reference standards for
I and II: Drug Schedule distribution to its customers for research
and analytical purposes.
Drug Schedule Cathinone (1235) .......................... I
Methcathinone (1237) .................. I No comments or objections have been
N-Ethylamphetamine (1475) ........ I received. DEA has considered the
Tetrahydrocannabinols (7370) ..... I factors in 21 U.S.C. 823(a) and 952(a)
Methaqualone (2565) ................... I
3,4–Methylenedioxy-methamphet- I Gamma hydroxybutyric acid I and determined that the registration of
amine (7405). (2010). Lipomed Inc. to import the basic classes
Cocaine (9041) ............................. II Lysergic acid diethylamide (7315), I of controlled substances is consistent
Oxycodone (9143) ........................ II 2,5-Dimethoxy-4-(n)- with the public interest and with United
Hydrocodone (9193) ..................... II propylthiophenethylamine States obligations under international
Methadone (9250) ........................ II (7438).
Marihuana (7360) ......................... I
treaties, conventions, or protocols in
Dextropropoxyphene, bulk (9273) II
Morphine (9300) ........................... II Tetrahydrocannabinols (7370) ..... I effect on May 1, 1971, at this time. DEA
Mescaline (7381) .......................... I has investigated Lipomed Inc. to ensure
3,4,5-Trimethoxyamphetamine I that the company’s registration is
The company plans to manufacture (7390). consistent with the public interest. The
the listed controlled substances as bulk 4-Bromo-2,5- I investigation has included inspection
reagents for use in drug abuse testing. dimethoxyamphetamine (7391). and testing of the company’s physical
4-Bromo-2,5- I security systems, verification of the
No comments or objections have been dimethoxyphenethylamine
received. DEA has considered the company’s compliance with State and
(7392).
factors in 21 U.S.C. 823(a) and 4-Methyl-2,5- I local laws, and a review of the
determined that the registration of Lin dimethoxyamphetamine (7395). company’s background and history.
Zhi International, Inc. to manufacture 2,5-Dimethoxyamphetamine I Therefore, pursuant to 21 U.S.C. 952(a)
the listed basic classes of controlled (7396). and 958(a), and in accordance with 21
substances is consistent with the public 2,5-Dimethoxy-4- I CFR 1301.34, the above named company
ethylamphetamine (7399). is granted registration as an importer of
interest at this time. DEA has 3,4-Methylenedioxyamphetamine I
investigated Lin Zhi International, Inc. the basic classes of controlled
(7400). substances listed.
to ensure that the company’s 3,4-Methylenedioxy-N- I
registration is consistent with the public ethylamphetamine (7404). Dated: November 28, 2006.
interest. The investigation has included 3,4- I Joseph T. Rannazzisi,
inspection and testing of the company’s Methylenedioxymethamphetam- Deputy Assistant Administrator, Office of
ine (7405). Diversion Control, Drug Enforcement
physical security systems, verification 4-Methoxyamphetamine (7411) ... I
of the company’s compliance with State Administration.
Dimethyltryptamine (7435) ........... I
and local laws, and a review of the Psilocybin (7437) .......................... I [FR Doc. E6–20745 Filed 12–6–06; 8:45 am]
company’s background and history. Psilocyn (7438) ............................. I BILLING CODE 4410–09–P
Therefore, pursuant to 21 U.S.C. 823, Acetyldihydrocodeine (9051) ........ I

and in accordance with 21 CFR 1301.33, Dihydromorphine (9145) ............... I
Heroin (9200) ............................... I DEPARTMENT OF JUSTICE
the above named company is granted Normorphine (9313) ..................... I
registration as a bulk manufacturer of Pholcodine (9314) ........................ I Drug Enforcement Administration
the basic classes of controlled Tilidine (9750) ............................... I
substances listed. Amphetamine (1100) .................... II Manufacturer of Controlled
Methamphetamine (1105) ............ II Substances; Notice of Registration
Dated: November 28, 2006. Amobarbital (2125) ....................... II
Joseph T. Rannazzisi, Pentobarbital (2270) ..................... II By Notice dated July 25, 2006, and
Deputy Assistant Administrator, Office of Secobarbital (2315) ...................... II published in the Federal Register on
Diversion Control, Drug Enforcement Phencyclidine (7471) .................... II July 31, 2006, (71 FR 43211), MGI
Administration. Cocaine (9041) ............................. II
Codeine (9050) ............................. II
Pharma, 6611 Tributary Street,
[FR Doc. E6–20693 Filed 12–6–06; 8:45 am] Baltimore, Maryland 21224, made
Dihydrocodeine (9120) ................. II
BILLING CODE 4410–09–P Oxycodone (9143) ........................ II application to the Drug Enforcement
Hydromorphone (9150) ................ II Administration (DEA) to be registered as
Benzoylecgonine (9180) ............... II a bulk manufacturer of Cocaine (9041),
VerDate Aug<31>2005 17:29 Dec 06, 2006 Jkt 211001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\07DEN1.SGM 07DEN1

Notice: Applications, Hearings, Determinations, Etc.: Lin Zhi International Inc.

Hochgeladen von

Dokumentinformationen

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Notice: Applications, Hearings, Determinations, Etc.: Lin Zhi International Inc.

Hochgeladen von

Copyright:

Verfügbare Formate

70986 Federal Register / Vol. 71, No.

235 / Thursday, December 7, 2006 / Notices

DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Schedule

Drug Enforcement Administration Drug Enforcement Administration Ethylmorphine (9190) ................... II

Therefore, pursuant to 21 U.S.C. 823, Acetyldihydrocodeine (9051) ........ I

Das könnte Ihnen auch gefallen